Richard F. Pops

Healthcare
Alkermes, Ireland
Ireland

Business Expert Pharmaceutical Sciences
Biography

 Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in 1991. Under his leadership, Alkermes has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 1,200 employees and a portfolio of more than 20 commercial products. Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, Acceleron Pharma, Epizyme, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA).

Research Intrest

 Developing innovative medicines for central nervous system (CNS) diseases with unmet needs.

Global Scientific Words in Pharmaceutical Sciences